My educational background is Clinical Medicine/General Surgery and I worked as a hepatobiliary surgeon in my country. I was registered as a PhD student at Professor Torkel B. Brismar Group in June 2018.
Research fields: hepatocellular carcinoma; quantitative assessment of liver function; gadoxetic acid enhanced MRI; radiomics and machine learning.
My PhD study is centered around how to accurately evaluate the liver function, especially the future liver remnant part, in patients with hepatocellular carcinoma before liver resection. We aim to establish non-invasive, accurate and reliable imaging biomarkers to evaluate (regional) liver function quantitatively based on preoperative gadoxetic acid enhanced MRI. With an ever-growing progress of artificial intelligence in the medical field, my current research is also making an attempt to apply machine learning approach (such as radiomics) to evaluate liver function, for instance to predict post-hepatectomy liver failure. We expect our research findings can supply a comprehensive estimation of the liver function for patients before liver resection, increase the number of patients as candidates for liver resection and assist to provide a safer and successful operation.
Predictive value of gadoxetic acid-enhanced MRI for posthepatectomy liver failure: a systematic review. Eur Radiol. 2021 Sep 25. Wang Q, Wang A, Sparrelid E, Zhang J, Zhao Y, Ma K, Brismar TB. doi: 10.1007/s00330-021-08297-8. Epub ahead of print.
Radiomics Models for Predicting Microvascular Invasion in Hepatocellular Carcinoma: A Systematic Review and Radiomics Quality Score Assessment. Cancers (Basel). 2021 Nov 22;13(22):5864. Wang Q, Li C, Zhang J, Hu X, Fan Y, Ma K, Sparrelid E, Brismar TB. doi: 10.3390/cancers13225864.
Rescue radiofrequency ablation or percutaneous ethanol injection: a strategy for failed RALPPS stage-1 in patients with cirrhosis-related hepatocellular carcinoma. BMC Surg. 2021 May 18;21(1):246. Wang Q, Chen S, Yan J, Brismar T, Sparrelid E, Qu C, Ji Y, Chen S, Ma K. doi: 10.1186/s12893-021-01241-z.
Sequential Portal Vein Embolization and Percutaneous Radiofrequency Ablation for Future Liver Remnant Growth: A Minimally Invasive Alternative to ALPPS Stage-1 in Treatment of Hepatocellular Carcinoma. Front Surg. 2021 Sep 30;8:741352. Wang Q, Ji Y, Brismar TB, Chen S, Li C, Jiang J, Mu W, Zhang L, Sparrelid E, Ma K. doi: 10.3389/fsurg.2021.741352.